Core Insights - The 17th China Bio-Industry Conference was held in Wuhan, showcasing China's strength and innovation in the bio-industry through policy interpretation, technical discussions, resource collaboration, international cooperation, and achievement transformation [1][2] - The conference highlighted China's rapid advancement in four key areas: biomedicine, bio-agriculture, biomass substitution, and bio-safety, with a focus on enhancing global influence and connectivity in the bio-economy [2] Industry Overview - The conference featured the release of the "China Bio-Economy Development Report 2025," which indicates that China is accelerating its position in the global value chain, leading in biotech patent applications and R&D personnel, and ranking second globally in biomedicine market size [1] - Approximately 30% of the world's innovative drugs under research are from China, with notable advancements in CAR-T cell therapy and brain-machine interfaces [1] Regional Development - Wuhan has developed a comprehensive biomedicine industry cluster centered around the Optics Valley Bio-City, covering the entire chain from innovation research and large-scale production to clinical applications, with an industry scale exceeding 550 billion RMB [2]